Company - MyBiotech
ABOUT US
0
ESTABLISHED
0
EMPLOYEES
0
COOPERATION PARTNERS WORLDWIDE
0
COMPLETED PROJECTS

MyBiotech is a CDMO on the fields of Biotechnology and Pharmaceuticals.

Biotechnological production is covered with all aspects of upstream and downstream processes focusing on cell disruption with our propriety technology and purification with chromatographic methods such as ion exchange and supercritical fluid chromatography. Biotechnological production of active pharmaceutical ingredients and natural substances is also one of the core aspects of our business. Our products include Algae derived Omega-3 fatty acids, innovative Omega-3 formulations Curcumin, Phycocyanin along with plant derived natural supplements.

Pharmaceutical division is specialized on development and technology transfer of nanoparticle and microparticle formulations from concept through development all the way up to GMP manufacturing. We are continuously developing and adapting innovative production methods for GMP manufacturing and processing of particulate systems. We support you with our innovative technologies to bring your project one step closer to success.

MANAGEMENT

Dr. Nazende Günday-Türeli
CEO

Nazende is a senior executive with 20+ years experience in research, consulting, strategical planning, business development strategy and management across life sciences and technology. She held leading positions of international pharma and biotech companies covering a broad range of disciplines under her umbrella. She brings an extensive knowledge of CMC of nanopharmaceuticals, building and growing technology driven businesses in the life sciences industry, and a proven track record of international success and reputation in innovation management and entrepreneurship in the pharma sector. She received her PhD in Biopharmaceutics and Pharmaceutical Technology MSc in Biotechnology from the University of Saarland, Germany.

Dr. Emre Türeli
CSO

Emre is the CSO of MyBiotech. He holds a PhD degree in Pharmaceutical Technology from Johannes Gutenberg University in Mainz, Germany. He is an internationally recognized scientist with more than 15 years of international research and development experience, as well as executive management experience in the pharmaceutical industry. He was the CEO and co-founder of former MJR Pharmjet. He has held management positions in various pharmaceutical companies. His expertise is on drug delivery systems, nanoparticle development and production method development in pharmaceutical industrial environment with strong focus on GMP compliance.

TEAM

Dr. Daniela Becher
Head of R&D Biotech

Daniela is the head of R&D Biotech and responsible for biotechnological projects with a focus on the biotechnological production and purification of Omega-3 fatty acids. She received her PhD in biotechnology from the University of Saarland, Germany. Daniela has vast experience in management of biotechnological projects and scientific education, as well as research and customer project management. Furthermore, she leaded a cell culture lab in a GMP and GLP certified international contract research organisation. At MyBiotech Daniela is responsible for the complete aspects of biotechnological processes.

Dipl.-Ing. (FH) Felix Penth
Head of technology development

.

2020

2020

Merger of MyBiotech and MJR PharmJet under the roof of MyBiotech GmbH

2016

2016

Foundation of the MyBiotech GmbH

2015

2015

Expansion, purchase and conversion of the Überherrn industrial campus, relocation

2013

2013

Foundation of Instillo GmbH; re-organization and transfer of administrative tasks and IP rights

2010

2010

Patenting of MJR-based processes in the pharmaceutical field

2010

2010

Application of MJR in the pharmaceutical sector by Dr. Emre Türeli, foundation of MJR PharmJet GmbH, Starterzentrum Homburg

1986

1986

Invention of the MicroJet Reactor (MJR) by Dr. Bernd Penth